healthcare
Research ReportsGlobal Platelet Agitator Market Propelled by 4.88% Cagr – Verified Market Reports®
TechnologyFrom Diagnostics to Ai: Seegene’s Technology-Sharing Vision to Future Pandemics
Top StoriesCentenarians Increased by 30% in Italy Over the Past Decade
InvestingNovo Nordisk CEO on Wegovy Prices, Supplies and Compounding
UK’s Queen Camilla Suffering From Chest Infection, Buckingham Palace Says
Date: November 6, 2024
LONDON (Reuters) -Queen Camilla, the wife of Britain’s King Charles, has been forced to pull out of her planned engagements this week after suffering a chest infection, Buckingham Palace said on Tuesday. Camilla, 77, is resting at home while she recovers but no further details of her illness have been given, as is usual with...
Citi Hires Top Dealmaker Jeff Stute From Perella to Bolster Healthcare M&A Ranks
Date: November 4, 2024
By Sabrina Valle NEW YORK (Reuters) – Jeff Stute, a veteran investment banker with a career spanning three decades at Perella Weinberg Partners and JPMorgan Chase, is joining Citigroup as a vice chair focused on healthcare mergers in North America, according to a memo seen by Reuters. The move is expected to bolster Citi’s healthcare...
BioNTech Lowers Full-Year Revenue Outlook on COVID-19 Seasonality, Inventory Write-Downs
Date: November 4, 2024
(Reuters) – German drugmaker BioNTech on Monday lowered its guidance for full-year revenue, citing COVID-19 uptake and price levels, inventory write-downs and Pfizer charges. The company now expects 2024 revenue to be at the low end of the guidance range of 2.5 to 3.1 billion euros ($2.72 – $3.38 billion). BioNTech, whose COVID-19 vaccine in...
King Charles Visits Melanoma Clinic in Sydney and Meets Cancer Survivors
Date: October 23, 2024
SYDNEY (Reuters) – King Charles visited a skin cancer clinic in Sydney on Tuesday where he met cancer survivors and researchers working on cures for the disease. The visit to the Melanoma Institute Australia was one of the final public appearances Charles made on his 16th official visit to the country, his first major...
Analysis-Can the New Cvs CEO Handle the Aetna Challenge?
Date: October 22, 2024
By Amina Niasse NEW YORK (Reuters) – As CVS Health’s new CEO David Joyner steps into the top job after Karen Lynch’s quick departure on Friday, Wall Street analysts and some investors are questioning whether he has the right experience to turn around the Aetna health insurance business as it struggles with high medical...
Pfizer Wins Bid to Invalidate GSK’s Patents Over Rsv Vaccine
Date: October 8, 2024
LONDON (Reuters) – Pfizer on Monday won a bid in a London court to invalidate two of GSK’s patents relating to a respiratory syncytial virus (RSV) vaccine. The two pharmaceutical giants are among a number of companies in competition for a vaccine for RSV, which typically causes cold-like symptoms but is also a leading...